Loading…
Loading…
Base rate computed from analyst-asserted responds_to: edges in the reverse direction (target-country → issuer-country) for prior issuer-actions on the same target. Modal type + lag percentiles only — not a model output. Treat as a historical anchor for sizing counter-response scenarios, not a forecast in itself.
MOFCOM Announcement No. 73 amends China's precursor-chemical export regime by (a) formally adding the US, Canada and Mexico to the "Specific Countries (Regions)" list under the Interim Provisions on the Management of Exports of Precursor Chemicals to Specific Countries (Regions), and (b) listing 13 categories of precursor chemicals that now require an export license specifically when the destination is one of those three countries. The underlying legal authority and license-application process are unchanged; the measure narrows only by destination, not by product scope globally.
The timing — effective the same day as the US executive order implementing the Busan arrangement's tariff-suspension terms (see 2025-10-30-us-china-busan-economic-trade-arrangement) — places this squarely as China's delivery on the fentanyl-precursor cooperation commitment made at the 30 October 2025 Trump-Xi summit, in exchange for the US halving its IEEPA-fentanyl tariff component from 20% to 10%. It is a cooperative/reciprocal enforcement action rather than an adversarial trade-control measure, distinguishing it from China's rare-earth/critical-minerals counter-strike actions issued under the same broader bilateral framework.
Severity is set low (2) and mixed: the quantitative anchor is the narrow scope (13 chemical categories, 3 destination countries, licensing rather than a ban), offset against the qualitative significance of being a concrete, dated deliverable inside a higher-stakes bilateral arrangement.
non-tariff commitments on schedule, which supports the durability of the broader one-year tariff-truce architecture.
categories (used in synthetic-opioid precursor synthesis) will need Chinese export licenses going forward, adding lead time to legitimate pharmaceutical and industrial-chemical supply chains sourcing from China.
the Chinese-language announcement) to identify any overlap with legitimate industrial or pharmaceutical intermediate chemicals beyond narcotics precursors.
reproduced in full in translated secondary coverage; the Chinese PDF attachment to the MOFCOM announcement should be checked for CAS numbers / HS codes if downstream tariff-line mapping is needed.
functioning as a de facto chokepoint, is not yet observable from the announcement text alone.